Efficacy and safety of 0.15 % isobutylamido thiazolyl resorcinol combined with hyaluronic acid versus 0.15 % isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator‐blind trial
2020 ◽
Vol 53
(8)
◽
Keyword(s):
2019 ◽
Vol 12
(1)
◽
pp. 48-54
Keyword(s):
2011 ◽
Vol 5
(S1)
◽
pp. 269-270
1997 ◽
Vol 171
(1)
◽
pp. 73-77
◽
Keyword(s):
Keyword(s):